Search Results - "Van Hooff, Johannes P."

Refine Results
  1. 1

    Lower Variability in 24-Hour Exposure During Once-Daily Compared to Twice-Daily Tacrolimus Formulation in Kidney Transplantation by Stifft, Frank, Stolk, Leo M.L, Undre, Nasrullah, van Hooff, Johannes P, Christiaans, Maarten H.L

    Published in Transplantation (15-04-2014)
    “…INTRODUCTIONTacrolimus has originally been registered as a twice-daily formulation (Prograf, Tac BID), although a once-daily formulation (Advagraf, Tac QD) is…”
    Get full text
    Journal Article
  2. 2

    Effect of Breakfast on the Exposure of the Once-Daily Tacrolimus Formulation in Stable Kidney Transplant Recipients by Stifft, Frank, Undre, Nasrullah, van Hooff, Johannes P, Christiaans, Maarten H L

    Published in Therapeutic drug monitoring (01-08-2016)
    “…The once-daily Tacrolimus formulation (Tac ONCE-DAILY) has to be taken on an empty stomach. This is inconvenient for patients and may hamper compliance. The…”
    Get full text
    Journal Article
  3. 3

    Early Loss of Peritubular Capillaries after Kidney Transplantation by STEEGH, Floortje M. E. G, GELENS, Marielle A. C. J, NIEMAN, Fred H. M, VAN HOOFF, Johannes P, CLEUTJENS, Jack P. M, JAN VAN SUYLEN, Robert, DAEMEN, Mat J. A. P, VAN HEURN, Ernst L. W, CHRISTIAANS, Maarten H. L, PEUTZ-KOOTSTRA, Carine J

    “…Inflammation, interstitial fibrosis (IF), and tubular atrophy (TA) precede chronic transplant dysfunction, which is a major cause of renal allograft loss…”
    Get full text
    Journal Article
  4. 4

    Similarities in Skeletal Muscle Strength and Exercise Capacity Between Renal Transplant and Hemodialysis Patients by Van Den Ham, Eugénie C.H., Kooman, Jeroen P., Schols, Annemie M.W.J., Nieman, Fred H.M., Does, Joan D., Franssen, Frits M.E., Akkermans, Marco A., Janssen, Paul P., Van Hooff, Johannes P.

    Published in American journal of transplantation (01-08-2005)
    “…Exercise intolerance is common in hemodialysis (HD) and renal transplant (RTx) patients. Aim of the study was to assess to what extent exercise capacity and…”
    Get full text
    Journal Article
  5. 5

    Lower variability in 24-hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation by Stifft, Frank, Stolk, Leo M L, Undre, Nasrullah, van Hooff, Johannes P, Christiaans, Maarten H L

    Published in Transplantation (15-04-2014)
    “…Tacrolimus has originally been registered as a twice-daily formulation (Prograf, Tac BID), although a once-daily formulation (Advagraf, Tac QD) is also…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Influence of tacrolimus on glucose metabolism before and after renal transplantation : A prospective study by VAN DUIJNHOVEN, Elly M, BOOTS, Johannes M. M, CHRISTIAANS, Maarten H. L, WOLFFENBUTTEL, Bruce H. R, VAN HOOFF, Johannes P

    “…Most studies concerning the influence of tacrolimus on glucose metabolism have been performed either in animals or after organ transplantation. These clinical…”
    Get full text
    Journal Article
  9. 9

    Effect of closure of the arteriovenous fistula on left ventricular dimensions in renal transplant patients by van Duijnhoven, Elly C. M., Cheriex, Emile C. M., Tordoir, Jan H. M., Kooman, Jeroen P., van Hooff, Johannes P.

    Published in Nephrology, dialysis, transplantation (01-02-2001)
    “…Background. Left ventricular hypertrophy is common in renal transplant patients. One of the factors that might contribute to this phenomenon is the persisting…”
    Get full text
    Journal Article
  10. 10

    Impact of CYP3A5 Genetic Polymorphism on Intrapatient Variability of Tacrolimus Exposure in Chinese Kidney Transplant Recipients by Cheung, Chi Yuen, Chan, Koon Ming, Wong, Yuen Ting, Chak, Wai Leung, Bekers, Otto, van Hooff, Johannes P.

    Published in Transplantation proceedings (01-07-2019)
    “…Although high tacrolimus (FK) intrapatient variability (IPV) was shown to be associated with poor graft outcome in kidney transplant recipients (KTRs), it is…”
    Get full text
    Journal Article
  11. 11
  12. 12

    No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12 years tacrolimus exposure by Gelens, Mariëlle ACJ, van Hooff, Johannes P, Usvyat, Len, Christiaans, Maarten H

    Published in Journal of diabetes and its complications (01-09-2017)
    “…Aims Tacrolimus (Tac) inhibits insulin secretion in a Tac-trough blood level dependent way earlypost-transplant in renal transplant recipients (Rtx). It is…”
    Get full text
    Journal Article
  13. 13

    Four-year experience with tacrolimus once-daily prolonged release in patients from phase II conversion and de novo kidney, liver, and heart studies by van Hooff, Johannes P., Alloway, Rita R., Trunečka, Pavel, Mourad, Michel

    Published in Clinical transplantation (01-01-2011)
    “…van Hooff JP, Alloway RR, Trunečka P, Mourad M. Four‐year experience with tacrolimus once‐daily prolonged release in patients from phase II conversion and de…”
    Get full text
    Journal Article
  14. 14

    Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant by PASCUAL, Julio, VAN HOOFF, Johannes P, SALMELA, Kaija, LONG, Philippe, RIGOTTI, Paolo, BUDDE, Klemens

    Published in Transplantation (15-07-2006)
    “…The challenge in renal transplantation is to improve long-term patient and graft survival without increasing early acute rejection by minimizing…”
    Get full text
    Journal Article
  15. 15

    No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12years tacrolimus exposure by Gelens, Mariëlle A.C.J., van Hooff, Johannes P., Usvyat, Len, Christiaans, Maarten H.

    Published in Journal of diabetes and its complications (01-09-2017)
    “…Tacrolimus (Tac) inhibits insulin secretion in a Tac-trough blood level dependent way early post-transplant in renal transplant recipients (Rtx). It is unknown…”
    Get full text
    Journal Article
  16. 16

    Clinical Relevance of Pretransplant Donor-Directed Antibodies Detected by Single Antigen Beads in Highly Sensitized Renal Transplant Patients by VAN DEN BERG-LOONEN, Ella M, BITTEN, Evy V. A, VOORTER, Christina E. M, VAN HEWN, L. W. Ernest, CLAAS, Frans H. J, VAN HOOF, Johannes P, CHRISTIAANS, Maarten H. L

    Published in Transplantation (27-04-2008)
    “…Highly sensitized (HS) patients (>85% panel-reactive antibodies) have a lower chance of receiving a donor kidney. Within Eurotransplant the Acceptable Mismatch…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Effect of immunosuppressive agents on long-term survival of renal transplant recipients: Focus on the cardiovascular risk by BOOTS, Johannes M. M, CHRISTIAANS, Maarten H. L, VAN HOOFF, Johannes P

    Published in Drugs (New York, N.Y.) (01-01-2004)
    “…In the control of acute rejection, attention is being focused more and more on the long-term adverse effects of the immunosuppressive agents used. Since…”
    Get full text
    Journal Article
  19. 19

    Tacrolimus and posttransplant diabetes mellitus in renal transplantation by VAN HOOFF, Johannes P, CHRISTIAANS, Maarten H. L, VAN DUIJNHOVEN, Elly M

    Published in Transplantation (15-06-2005)
    “…The most prominent side effect of tacrolimus is the induction of posttransplant diabetes mellitus (PTDM). In this review, the authors discuss the incidence,…”
    Get full text
    Journal Article
  20. 20

    Evaluating mechanisms of post-transplant diabetes mellitus by van Hooff, Johannes P., Christiaans, Maarten H. L., van Duijnhoven, Elly M.

    Published in Nephrology, dialysis, transplantation (01-12-2004)
    “…Post-transplant diabetes mellitus (PTDM) is a frequent complication in renal transplantation. While both tacrolimus and ciclosporin are known to be associated…”
    Get full text
    Journal Article Conference Proceeding